Kindred Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KIN and buy or sell other stocks, ETFs, and their options commission-free!About KIN
Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals.
CEORichard H. Chin, MD
CEORichard H. Chin, MD
Employees—
Employees—
HeadquartersBurlingame, California
HeadquartersBurlingame, California
Founded2012
Founded2012
Employees—
Employees—
KIN Key Statistics
Market cap420.53M
Market cap420.53M
Price-Earnings ratio-9.02
Price-Earnings ratio-9.02
Dividend yield—
Dividend yield—
Average volume648.56K
Average volume648.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.28
52 Week high$9.28
52 Week low$3.46
52 Week low$3.46
Stock Snapshot
Kindred Biosciences(KIN) stock is priced at $9.25, giving the company a market capitalization of 420.53M. It carries a P/E multiple of -9.02.
During the trading day, Kindred Biosciences(KIN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 648.56K.
Over the past 52 weeks, Kindred Biosciences(KIN) stock has traded between a high of $9.28 and a low of $3.46.
Over the past 52 weeks, Kindred Biosciences(KIN) stock has traded between a high of $9.28 and a low of $3.46.
People also own
Based on the portfolios of people who own KIN. This list is generated using Robinhood data, and it’s not a recommendation.